To investigate whether conversion from the basal to luminal-like subtype upon 5’-azacitidine treatment is mediated by elevated expression of Hh in tumor cells, we performed orthotopic transplantation of BBN-induced tumor organoids engineered to express shRNA targeting Shh (Figure 5A and Figure 5—figure supplement 1A). This evidence concerns the gene SHH and neoplasm.